Format

Send to

Choose Destination
Clin Orthop Relat Res. 2010 Dec;468(12):3255-62. doi: 10.1007/s11999-010-1340-6.

Constrained liner in neurologic or cognitively impaired patients undergoing primary THA.

Author information

1
Department of Orthopaedic Surgery, University Paris XII, Hôpital Henri Mondor, 94010, Creteil, France. philippe.hernigou@wanadoo.fr

Abstract

BACKGROUND:

THA performed in patients with cognitive deficits or neuromuscular diseases has been associated with a high postoperative dislocation rate. The constrained liner reportedly provides stability in patients with recurrent dislocation. However, achieving stability could be offset by early loosening when used in patients with neurologic diseases.

QUESTIONS/PURPOSES:

We therefore asked whether constrained liners had a higher risk of loosening when used in primary THA for patients with neurologic diseases.

METHODS:

We retrospectively reviewed a 144 patients (164 hips) with neuromuscular disease who had a constrained polyethylene insert from 1999 to 2004 and compared them to another 120 patients (132 hips) with neuromuscular disease operated on immediately before this period (from 1994 to 1998) who had a conventional polyethylene insert.

RESULTS:

Thirty-three (25%) of the 132 hips without a constrained liner were known to have had at least one dislocation and 21 had revision for recurrent dislocation. Ten other hips had revision for loosening of the cup. The survival rate was 82% at 5 years and 77% at 10 years with revision due to recurrent dislocation or loosening of the cup as the endpoint. With a constrained liner, at minimum 5-year followup (mean, 7 years; range, 5-10 years), the incidence of complications, particularly dislocation, was decreased (three dislocations among 164 hips; 2%), with one revision for recurrent dislocation and one revision for loosening.

CONCLUSIONS:

This constrained acetabular component provides durable protection against dislocation without substantial increased loosening at midterm followup.

PMID:
20376709
PMCID:
PMC2974891
DOI:
10.1007/s11999-010-1340-6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center